Control Share Statute vs Poison Pill: How They Compare

A control-share statute is a state law that strips voting rights from anyone acquiring a threshold percentage (often 20%) of a company’s shares unless a majority of existing shareholders vote to restore those rights; a poison pill is a contract right that dilutes the acquirer’s stake by issuing new shares to existing shareholders if the acquirer crosses a trigger (often 15–20%). Both block hostile takeovers, but through opposite levers: legal disenfranchisement versus economic dilution.

The control-share statute: disenfranchisement by law

A control-share acquisition statute is enacted at the state level and automatically applies to corporations incorporated in that state (unless the corporation opts out in its charter).

The statute works like this:

1. Any person acquiring shares in excess of a threshold percentage (commonly 20%, but varies by state) must notify the company.
2. The shares acquired above that threshold are automatically rendered non-voting.
3. The acquirer can petition for a shareholder vote to restore voting rights.
4. If a majority of shares voted by disinterested shareholders approve, the shares become voting again. If not, they remain non-voting indefinitely (though the acquirer retains economic rights—dividends and proceeds on liquidation).

Indiana was the first state to adopt a control-share statute, in 1986. It was immediately challenged as unconstitutional under the Commerce Clause, but the Supreme Court upheld it in CTS Corp. v. Dynamics Corp. of America (1987). Today, roughly 30 states have control-share statutes.

The statute is automatic and requires no board action. Unlike a poison pill, which the board must approve and deploy, a control-share statute operates by force of law.

The poison pill: dilution through shareholder rights plans

A poison pill (formally, a “shareholder rights plan” or “flip-in plan”) is a contract—typically adopted by the board without a shareholder vote—that grants existing shareholders the right to purchase additional shares at a deep discount if an acquirer crosses a trigger threshold.

The mechanism:

1. The board issues a “right” to each outstanding share, exercisable only under specified conditions.
2. If someone acquires (or announces an intent to acquire) more than a trigger percentage—often 15%, but ranges from 10% to 25%—the pill “flips in.”
3. All shareholders except the acquirer receive the right to buy additional shares (typically at 50% of market price).
4. The result: the acquirer’s ownership stake is diluted (e.g., from 20% to 10%) while existing shareholders’ stakes are preserved relative to each other.

The pill is purely contractual and does not disable voting; it just makes the acquisition economically catastrophic for the raider. If the acquirer owns 20% and the pill doubles the share count (while excluding them), their stake drops to 10% post-exercise.

The pill requires board action to adopt. It is typically included in the company’s charter or bylaws and can be redeemed (canceled) by the board at any time—usually after the threat passes or as a condition of a negotiated deal.

Direct comparison: mechanism and effect

Why a raider fears both—and why they work together

A hostile acquirer dreads both mechanisms because they operate on different margins.

Control-share statute: Even if the acquirer owns 30% of shares, those shares might be non-voting. They can attend meetings and receive dividends but cannot elect directors or vote on key decisions. The acquirer is frozen out of control until it wins a shareholder vote—a vote that existing shareholders, who benefit from a higher bid, will likely reject. This is extremely credible because it is law.

Poison pill: The acquirer owns the shares but their stake is mathematically destroyed if the pill is exercised. A 20% stake becomes 10% (or less). To take the company, the acquirer must either (a) negotiate with the board to redeem the pill, or (b) win a proxy fight, replace the board, and instruct the new board to redeem. Both take time and money.

A company can adopt both. If an acquirer crosses the trigger for a pill, the board can immediately exercise it (or threaten to). If the acquirer presses on, the control-share statute becomes relevant: when they try to vote their shares, they discover those above the threshold are non-voting. The two defenses reinforce each other.

Which states have control-share statutes?

Control-share statutes exist in approximately 30 US states, including Indiana, Ohio, Pennsylvania, New York, and Illinois. However, most modern corporations incorporate in Delaware (or Nevada), which does not have a control-share statute.

Delaware is a choice because:

• It offers flexibility in charter design (companies can opt out of hypothetical statutes).
• Its courts have sophisticated corporate law and predictable rulings.
• Takeover defenses like the pill are legally safe under Delaware law, but the pill requires board action and can be redeemed.

A raider is much less deterred by a pill in Delaware than by automatic control-share disenfranchisement in Indiana. This is why control-share statutes remain economically relevant: they bind companies to a state and limit the board’s ability to negotiate.

Effectiveness: why pills are more common, but control-share is stronger

In practice, companies rely far more heavily on poison pills than control-share statutes, for a simple reason: pills are negotiable and redeemable. The board can deploy a pill to raise the acquirer’s cost, then redeem it once the price is right. This preserves the board’s negotiating power and limits shareholder litigation (boards can claim they extracted value).

Control-share statutes are blunt. They cannot be negotiated away by the board; they are law. An acquirer must either win a shareholder vote (usually unachievable unless the offer is wildly attractive) or litigate. This explains why raiders prefer to target Delaware corporations: the pill is merely a bargaining chip.

However, control-share statutes have declined in economic importance since the 1990s because most major corporations incorporated or reincorporated in Delaware to escape them. The statute thus acts as a “moat” for companies incorporated in statute states, but not for the universe of takeover targets.

The shareholder vote problem: who decides?

Both mechanisms ultimately defer to shareholder approval or corporate structure, but in opposite ways.

With a control-share statute, the acquirer can force a vote. Existing shareholders decide whether to grant voting rights. The outcome is unpredictable: if the acquirer’s offer is generous, shareholders may approve. If it is stingy, they reject.

With a poison pill, the board controls whether to redeem. Shareholders cannot force redemption (under most state laws and Delaware court precedent). Only a successful proxy fight to replace the board, followed by redemption, can remove the pill. This is mechanically harder than winning a shareholder vote—it requires the acquirer to not only convince shareholders that the pill should go but also to identify and elect a new board.

Modern best practices have tilted toward pills that include a “fiduciary out”—a clause allowing the board to redeem the pill without shareholder approval if it receives a superior offer. This balances the board’s fiduciary duty to shareholders (to negotiate fairly) with the defense’s function (to raise the asking price).

See also